NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SNOA
Sonoma Pharmaceuticals, Inc.
There isn't enough reported data to score SNOA yet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SNOA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Weak | |
| Unavailable |
SNOA's revenue is currently strong, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
SNOA PE Valuation
SNOA has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
SNOA Forward outlook
There aren't enough analyst estimates for SNOA to show an outlook.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over SNOA on earnings quality, reporting a profit while its opponent remains loss making.
SNOA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.91 | +$2.30 |
| Q2 2026 | -$1.22 | +$2.26 |
| Q1 2026 | -$1.89 | +$2.23 |
| Q4 2021 | -$54.20 | -$33.60 |
| Q3 2021 | -$54.40 | -$25.80 |
| Q2 2021 | -$52.40 | -$4.40 |
| Q1 2021 | -$39.40 | +$0.40 |
SNOA is still losing money, but far less than before: $0.91 per share over the past year, against $54.40 at its worst in late 2021.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over SNOA on profitability, with a higher operating margin.
SNOA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2M | +28% |
| Q2 2026 | $6.4M | +60% |
| Q1 2026 | $5.6M | +48% |
| Q4 2025 | $4.3M | +22% |
| Q3 2025 | $5.6M | +57% |
| Q2 2025 | $4M | +18% |
| Q1 2025 | $3.8M | +9.2% |
| Q4 2024 | $3.6M | +14% |
SNOA has the edge over NVO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +10 points |
| Q2 2026 | -0.6% | +27 points |
| Q1 2026 | -6.3% | +11 points |
| Q4 2025 | -16% | +13 points |
| Q3 2025 | -6% | +18 points |
| Q2 2025 | -27% | +7.3 points |
| Q1 2025 | -17% | +24 points |
| Q4 2024 | -29% | -2 points |
SNOA's operating margin was 4% last quarter, up 10 points from the same quarter a year ago, near the top of its range since 2019.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over SNOA on cash generation, producing positive trailing cash flow while its opponent burns cash.
SNOA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$778K | -$133K |
| Q2 2026 | -$651K | +$1.5M |
| Q1 2026 | -$548K | -$406K |
| Q4 2025 | -$811K | -244% |
| Q3 2025 | -$645K | -297% |
| Q2 2025 | -$2.1M | -$1.2M |
| Q1 2025 | -$142K | -192% |
| Q4 2024 | $563K | +$1.7M |
SNOA has burned cash in almost every quarter: −$3M over the past year, against −$2M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over SNOA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
SNOA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +28% | +1.1M shares |
| 1 year | +199% | +3.3M shares |
| 3 years | +4591% | +4.8M shares |
SNOA has 5M diluted shares, up 199% from a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
SNOA Net Leverage
SNOA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
SNOA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 18.2 | Oversold |
SNOA's weekly RSI is 38 (neutral) and its Stochastic is 18 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
SNOA PE vs Healthcare Sector
SNOA has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
SNOA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.17 | 0% above |
| 20 week MA | $1.23 | 4.9% below |
| 50 week MA | $1.91 | 39% below |
| 100 week MA | $2.60 | 55% below |
| 200 week MA | $6.66 | 82% below |
SNOA is in a downtrend: it's below all five of its weekly moving averages, and 82% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over SNOA on returns for 2026, with the stronger performance.
SNOA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $88.2 | $163.6 | +85% |
| 2021 | $163.6 | $97.0 | -41% |
| 2022 | $97.0 | $23.0 | -76% |
| 2023 | $23.0 | $3.61 | -84% |
| 2024 | $3.61 | $2.75 | -24% |
| 2025 | $2.75 | $3.61 | +31% |
| 2026 YTD | $3.61 | $1.17 | -68% |
SNOA has finished lower in four of the last six years. It's down 68% so far in 2026.